Ain Shams University: Toxemia trials

The registry lists 11 Toxemia studies with Ain Shams University as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 3Phase 4 2No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU PatientsRecruitingNCT06915974Not applicable
• Observational Study About the Use of Perfusion Index to Use Vasopressor in SepsisRecruitingNCT06860438
• SOFA Score with Serum Procalcitonin Versus SOFA Score with Neutrophil/lymphocyte Ratio in Predicting Sepsis and Clinical Outcomes in I.C.U.Not yet recruitingNCT06847477
• PSP as Indicator for Urinary Sepsis in ICUNot yet recruitingNCT06090526
• Role of Vitamin D Therapy in Recovery From Early Neonatal Sepsis (Randomized Controlled Trial)CompletedNCT05969327Phase 3
• Alpha-Lipoic Acid in Patients With SepsisStatus unknownNCT05808946Phase 2/3
• Heparin Binding Protein as a Prognostic Biomarker of Sepsis SeverityCompletedNCT05610020
• Effect of Montelukast Versus Co Enzyme in SepsisCompletedNCT05293132Phase 2/3
• Outcome of High Dose Vitamin D on Prognosis of Sepsis Requiring Mechanical VentilationCompletedNCT05244018Phase 4
• Red Cell Distribution Width Versus Presepsin (Soluble CD14) as a Prognostic Marker in Critically-ill Sepsis PatientsCompletedNCT03796715
• Early Versus Late Lactoferrin in Prevention of Neonatal SepsisCompletedNCT02959229Phase 4